Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer

Journal of Genetics and Genomics

Volumn 41, Issue 4, 2014, Pages 187-195

  Zhang, Zhiqian ^a   Zhu, Zhengmao ^a   Zhang, Baotong ^a   Li, Weidong ^b   Li, Xin ^a   Wu, Xiao ^a   Wang, Lijuan ^a   Fu, Liya ^a   Fu, Li ^b   Dong, Jin Tang ^a,c  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; ER; MiRNA; Mutation; MYC; PVT1; Rs13281615; SNP

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN; PLASMACYTOMA VARIANT TRANSLOCATION 1 PROTEIN; UNCLASSIFIED DRUG; LONG UNTRANSLATED RNA; PVT1 LONG-NON-CODING RNA, HUMAN;

ADULT; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GRADING; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CHINESE; CHROMOSOME 8Q; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE MYC; PRIMARY TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CHROMOSOME 8; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; MUTATION; PATHOLOGY; RISK FACTOR; TUMOR CELL LINE;

AVES;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, LONG NONCODING;

EID: 84899629465     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2014.03.006     Document Type: Article

References (39)

1. Ahmadiyeh N., Pomerantz M.M., Grisanzio C., Herman P., Jia L., Almendro V., He H.H., Brown M., Liu X.S., Davis M., Caswell J.L., Beckwith C.A., Hills A., Macconaill L., Coetzee G.A., Regan M.M., Freedman M.L. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 2010, 107:9742-9746.
2. Beck-Engeser G.B., Lum A.M., Huppi K., Caplen N.J., Wang B.B., Wabl M. Pvt1-encoded microRNAs in oncogenesis. Retrovirology 2008, 5:4.
3. Boehm T., Rabbitts T.H. The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors. FASEB J. 1989, 3:2344-2359.
4. Broeks A., Schmidt M.K., Sherman M.E., Couch F.J., Hopper J.L., Dite G.S., Apicella C., Smith L.D., Hammet F., Southey M.C., Van 't Veer L.J., de Groot R., Smit V.T., Fasching P.A., Beckmann M.W., Jud S., Ekici A.B., Hartmann A., Hein A., Schulz-Wendtland R., Burwinkel B., Marme F., Schneeweiss A., Sinn H.P., Sohn C., Tchatchou S., Bojesen S.E., Nordestgaard B.G., Flyger H., Orsted D.D., Kaur-Knudsen D., Milne R.L., Perez J.I., Zamora P., Rodriguez P.M., Benitez J., Brauch H., Justenhoven C., Ko Y.D., Hamann U., Fischer H.P., Bruning T., Pesch B., Chang-Claude J., Wang-Gohrke S., Bremer M., Karstens J.H., Hillemanns P., Dork T., Nevanlinna H.A., Heikkinen T., Heikkila P., Blomqvist C., Aittomaki K., Aaltonen K., Lindblom A., Margolin S., Mannermaa A., Kosma V.M., Kauppinen J.M., Kataja V., Auvinen P., Eskelinen M., Soini Y., Chenevix-Trench G., Spurdle A.B., Beesley J., Chen X., Holland H., Lambrechts D., Claes B., Vandorpe T., Neven P., Wildiers H., Flesch-Janys D., Hein R., Loning T., Kosel M., Fredericksen Z.S., Wang X., Giles G.G., Baglietto L., Severi G., McLean C., Haiman C.A., Henderson B.E., Le Marchand L., Kolonel L.N., Alnaes G.G., Kristensen V., Borresen-Dale A.L., Hunter D.J., Hankinson S.E., Andrulis I.L., Mulligan A.M., O'Malley F.P., Devilee P., Huijts P.E., Tollenaar R.A., Van Asperen C.J., Seynaeve C.S., Chanock S.J., Lissowska J., Brinton L., Peplonska B., Figueroa J., Yang X.R., Hooning M.J., Hollestelle A., Oldenburg R.A., Jager A., Kriege M., Ozturk B., van Leenders G.J., Hall P., Czene K., Humphreys K., Liu J., Cox A., Connley D., Cramp H.E., Cross S.S., Balasubramanian S.P., Reed M.W., Dunning A.M., Easton D.F., Humphreys M.K., Caldas C., Blows F., Driver K., Provenzano E., Lubinski J., Jakubowska A., Huzarski T., Byrski T., Cybulski C., Gorski B., Gronwald J., Brennan P., Sangrajrang S., Gaborieau V., Shen C.Y., Hsiung C.N., Yu J.C., Chen S.T., Hsu G.C., Hou M.F., Huang C.S., Anton-Culver H., Ziogas A., Pharoah P.D., Garcia-Closas M. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum. Mol. Genet. 2011, 20:3289-3303.
5. Carramusa L., Contino F., Ferro A., Minafra L., Perconti G., Giallongo A., Feo S. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J. Cell. Physiol. 2007, 213:511-518.
6. Chan M., Ji S.M., Liaw C.S., Yap Y.S., Law H.Y., Yoon C.S., Wong C.Y., Yong W.S., Wong N.S., Ng R., Ong K.W., Madhukumar P., Oey C.L., Tan P.H., Li H.H., Ang P., Ho G.H., Lee A.S. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Res. Treat. 2012, 136:209-220.
7. Dworkin A.M., Ridd K., Bautista D., Allain D.C., Iwenofu O.H., Roy R., Bastian B.C., Toland A.E. Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet. 2010, 6:e1001136.
8. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C.S., Bowman R., Meyer K.B., Haiman C.A., Kolonel L.K., Henderson B.E., Le Marchand L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C.Y., Wu P.E., Wang H.C., Eccles D., Evans D.G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M.R., Rahman N., Chenevix-Trench G., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Hunter D.J., Hankinson S.E., Cox D.G., Hall P., Wedren S., Liu J., Low Y.L., Bogdanova N., Schurmann P., Dork T., Tollenaar R.A., Jacobi C.E., Devilee P., Klijn J.G., Sigurdson A.J., Doody M.M., Alexander B.H., Zhang J., Cox A., Brock I.W., MacPherson G., Reed M.W., Couch F.J., Goode E.L., Olson J.E., Meijers-Heijboer H., van den Ouweland A., Uitterlinden A., Rivadeneira F., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J.L., McCredie M., Southey M., Giles G.G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y.D., Spurdle A.B., Beesley J., Chen X., Mannermaa A., Kosma V.M., Kataja V., Hartikainen J., Day N.E., Cox D.R., Ponder B.A. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
9. Feo S., Di Liegro C., Jones T., Read M., Fried M. The DNA region around the c-myc gene and its amplification in human tumour cell lines. Oncogene 1994, 9:955-961.
10. Fletcher O., Johnson N., Gibson L., Coupland B., Fraser A., Leonard A., dos Santos Silva I., Ashworth A., Houlston R., Peto J. Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:702-705.
11. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., Stratton M.R. A census of human cancer genes. Nat. Rev. Cancer 2004, 4:177-183.
12. Garcia-Closas M., Hall P., Nevanlinna H., Pooley K., Morrison J., Richesson D.A., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Arias J.I., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Zamora P., Brauch H., Justenhoven C., Hamann U., Ko Y.D., Bruening T., Haas S., Dork T., Schurmann P., Hillemanns P., Bogdanova N., Bremer M., Karstens J.H., Fagerholm R., Aaltonen K., Aittomaki K., von Smitten K., Blomqvist C., Mannermaa A., Uusitupa M., Eskelinen M., Tengstrom M., Kosma V.M., Kataja V., Chenevix-Trench G., Spurdle A.B., Beesley J., Chen X., Devilee P., van Asperen C.J., Jacobi C.E., Tollenaar R.A., Huijts P.E., Klijn J.G., Chang-Claude J., Kropp S., Slanger T., Flesch-Janys D., Mutschelknauss E., Salazar R., Wang-Gohrke S., Couch F., Goode E.L., Olson J.E., Vachon C., Fredericksen Z.S., Giles G.G., Baglietto L., Severi G., Hopper J.L., English D.R., Southey M.C., Haiman C.A., Henderson B.E., Kolonel L.N., Le Marchand L., Stram D.O., Hunter D.J., Hankinson S.E., Cox D.G., Tamimi R., Kraft P., Sherman M.E., Chanock S.J., Lissowska J., Brinton L.A., Peplonska B., Hooning M.J., Meijers-Heijboer H., Collee J.M., van den Ouweland A., Uitterlinden A.G., Liu J., Lin L.Y., Yuqing L., Humphreys K., Czene K., Cox A., Balasubramanian S.P., Cross S.S., Reed M.W., Blows F., Driver K., Dunning A., Tyrer J., Ponder B.A., Sangrajrang S., Brennan P., McKay J., Odefrey F., Gabrieau V., Sigurdson A., Doody M., Struewing J.P., Alexander B., Easton D.F., Pharoah P.D. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008, 4:e1000054.
13. Ghoussaini M., Song H., Koessler T., Al Olama A.A., Kote-Jarai Z., Driver K.E., Pooley K.A., Ramus S.J., Kjaer S.K., Hogdall E., DiCioccio R.A., Whittemore A.S., Gayther S.A., Giles G.G., Guy M., Edwards S.M., Morrison J., Donovan J.L., Hamdy F.C., Dearnaley D.P., Ardern-Jones A.T., Hall A.L., O'Brien L.T., Gehr-Swain B.N., Wilkinson R.A., Brown P.M., Hopper J.L., Neal D.E., Pharoah P.D., Ponder B.A., Eeles R.A., Easton D.F., Dunning A.M. Multiple loci with different cancer specificities within the 8q24 gene desert. J. Natl. Cancer Inst. 2008, 100:962-966.
14. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., Friedman E., Narod S., Olshen A.B., Gregersen P., Kosarin K., Olsh A., Bergeron J., Ellis N.A., Klein R.J., Clark A.G., Norton L., Dean M., Boyd J., Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc. Natl. Acad. Sci. USA 2008, 105:4340-4345.
15. Gong W.F., Zhong J.H., Xiang B.D., Ma L., You X.M., Zhang Q.M., Li L.Q. Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases. PLoS ONE 2013, 8:e60108.
16. Guan Y., Kuo W.L., Stilwell J.L., Takano H., Lapuk A.V., Fridlyand J., Mao J.H., Yu M., Miller M.A., Santos J.L., Kalloger S.E., Carlson J.W., Ginzinger D.G., Celniker S.E., Mills G.B., Huntsman D.G., Gray J.W. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin. Cancer Res. 2007, 13:5745-5755.
17. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
18. Jia L., Landan G., Pomerantz M., Jaschek R., Herman P., Reich D., Yan C., Khalid O., Kantoff P., Oh W., Manak J.R., Berman B.P., Henderson B.E., Frenkel B., Haiman C.A., Freedman M., Tanay A., Coetzee G.A. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet. 2009, 5:e1000597.
19. Jiang Y., Han J., Liu J., Zhang G., Wang L., Liu F., Zhang X., Zhao Y., Pang D. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. Breast Cancer Res. Treat. 2011, 128:251-257.
20. Knudson A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 2001, 1:157-162.
21. Long J., Shu X.O., Cai Q., Gao Y.T., Zheng Y., Li G., Li C., Gu K., Wen W., Xiang Y.B., Lu W., Zheng W. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol. Biomarkers Prev. 2010, 19:2357-2365.
22. McInerney N., Colleran G., Rowan A., Walther A., Barclay E., Spain S., Jones A.M., Tuohy S., Curran C., Miller N., Kerin M., Tomlinson I., Sawyer E. Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res. Treat. 2009, 117:151-159.
23. Meyer K.B., Maia A.T., O'Reilly M., Ghoussaini M., Prathalingam R., Porter-Gill P., Ambs S., Prokunina-Olsson L., Carroll J., Ponder B.A. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet. 2011, 7:e1002165.
24. Munger K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 2002, 20:71-81.
25. Nagoshi H., Taki T., Hanamura I., Nitta M., Otsuki T., Nishida K., Okuda K., Sakamoto N., Kobayashi S., Yamamoto-Sugitani M., Tsutsumi Y., Kobayashi T., Matsumoto Y., Horiike S., Kuroda J., Taniwaki M. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012, 72:4954-4962.
26. Odefrey F., Stone J., Gurrin L.C., Byrnes G.B., Apicella C., Dite G.S., Cawson J.N., Giles G.G., Treloar S.A., English D.R., Hopper J.L., Southey M.C. Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res. 2010, 70:1449-1458.
27. Pathmanathan N., Balleine R.L. Ki67 and proliferation in breast cancer. J. Clin. Pathol. 2013, 66:512-516.
28. Pomerantz M.M., Ahmadiyeh N., Jia L., Herman P., Verzi M.P., Doddapaneni H., Beckwith C.A., Chan J.A., Hills A., Davis M., Yao K., Kehoe S.M., Lenz H.J., Haiman C.A., Yan C., Henderson B.E., Frenkel B., Barretina J., Bass A., Tabernero J., Baselga J., Regan M.M., Manak J.R., Shivdasani R., Coetzee G.A., Freedman M.L. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 2009, 41:882-884.
29. Pomerantz M.M., Beckwith C.A., Regan M.M., Wyman S.K., Petrovics G., Chen Y., Hawksworth D.J., Schumacher F.R., Mucci L., Penney K.L., Stampfer M.J., Chan J.A., Ardlie K.G., Fritz B.R., Parkin R.K., Lin D.W., Dyke M., Herman P., Lee S., Oh W.K., Kantoff P.W., Tewari M., McLeod D.G., Srivastava S., Freedman M.L. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res. 2009, 69:5568-5574.
30. Sotelo J., Esposito D., Duhagon M.A., Banfield K., Mehalko J., Liao H., Stephens R.M., Harris T.J., Munroe D.J., Wu X. Long-range enhancers on 8q24 regulate c-Myc. Proc. Natl. Acad. Sci. USA 2010, 107:3001-3005.
31. Sur I.K., Hallikas O., Vaharautio A., Yan J., Turunen M., Enge M., Taipale M., Karhu A., Aaltonen L.A., Taipale J. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 2012, 338:1360-1363.
32. Takatsuno Y., Mimori K., Yamamoto K., Sato T., Niida A., Inoue H., Imoto S., Kawano S., Yamaguchi R., Toh H., Iinuma H., Ishimaru S., Ishii H., Suzuki S., Tokudome S., Watanabe M., Tanaka J., Kudo S.E., Mochizuki H., Kusunoki M., Yamada K., Shimada Y., Moriya Y., Miyano S., Sugihara K., Mori M. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Ann. Surg. Oncol. 2013, 20:1395-1402.
33. Thomas G., Jacobs K.B., Kraft P., Yeager M., Wacholder S., Cox D.G., Hankinson S.E., Hutchinson A., Wang Z., Yu K., Chatterjee N., Garcia-Closas M., Gonzalez-Bosquet J., Prokunina-Olsson L., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Diver R., Prentice R., Jackson R., Kooperberg C., Chlebowski R., Lissowska J., Peplonska B., Brinton L.A., Sigurdson A., Doody M., Bhatti P., Alexander B.H., Buring J., Lee I.M., Vatten L.J., Hveem K., Kumle M., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F., Hoover R.N., Chanock S.J., Hunter D.J. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat. Genet. 2009, 41:579-584.
34. Turnbull C., Ahmed S., Morrison J., Pernet D., Renwick A., Maranian M., Seal S., Ghoussaini M., Hines S., Healey C.S., Hughes D., Warren-Perry M., Tapper W., Eccles D., Evans D.G., Hooning M., Schutte M., van den Ouweland A., Houlston R., Ross G., Langford C., Pharoah P.D., Stratton M.R., Dunning A.M., Rahman N., Easton D.F. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010, 42:504-507.
35. Tuupanen S., Turunen M., Lehtonen R., Hallikas O., Vanharanta S., Kivioja T., Bjorklund M., Wei G., Yan J., Niittymaki I., Mecklin J.P., Jarvinen H., Ristimaki A., Di-Bernardo M., East P., Carvajal-Carmona L., Houlston R.S., Tomlinson I., Palin K., Ukkonen E., Karhu A., Taipale J., Aaltonen L.A. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 2009, 41:885-890.
36. Wasserman N.F., Aneas I., Nobrega M.A. An 8q24 gene desert variant associated with prostate cancer risk confers differential invivo activity to a MYC enhancer. Genome Res. 2010, 20:1191-1197.
37. Wright J.B., Brown S.J., Cole M.D. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell. Biol. 2010, 30:1411-1420.
38. You L., Chang D., Du H.Z., Zhao Y.P. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2011, 407:1-6.
39. Zheng W., Wen W., Gao Y.T., Shyr Y., Zheng Y., Long J., Li G., Li C., Gu K., Cai Q., Shu X.O., Lu W. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J. Natl. Cancer Inst. 2010, 102:972-981.